These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23798695)

  • 1. The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?
    Maiden MC
    Philos Trans R Soc Lond B Biol Sci; 2013 Aug; 368(1623):20120147. PubMed ID: 23798695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bacterial polysaccharide vaccines: Meningococcus, Pneumococcus, Haemophilus influenzae].
    Triau R
    Rev Prat; 1984 Jun; 34(31):1683-90. PubMed ID: 6429835
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
    Blanchard-Rohner G; Pollard AJ
    Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.
    Martin NG; Sadarangani M; Pollard AJ; Goldacre MJ
    Lancet Infect Dis; 2014 May; 14(5):397-405. PubMed ID: 24631222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
    Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
    Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.
    Pollard AJ; Perrett KP; Beverley PC
    Nat Rev Immunol; 2009 Mar; 9(3):213-20. PubMed ID: 19214194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protecting the herd: the remarkable effectiveness of the bacterial meningitis polysaccharide-protein conjugate vaccines in altering transmission dynamics.
    Stephens DS
    Trans Am Clin Climatol Assoc; 2011; 122():115-23. PubMed ID: 21686214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children.
    Eskola J; Käyhty H; Takala A; Rönnberg PR; Kela E; Peltola H
    Vaccine; 1990 Apr; 8(2):107-10. PubMed ID: 2110703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vaccines on bacterial meningitis worldwide.
    McIntyre PB; O'Brien KL; Greenwood B; van de Beek D
    Lancet; 2012 Nov; 380(9854):1703-11. PubMed ID: 23141619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugate vaccines--a breakthrough in vaccine development.
    Mäkelä PH
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of bacterial meningitis. Vaccines and chemoprophylaxis.
    Lieberman JM; Greenberg DP; Ward JI
    Infect Dis Clin North Am; 1990 Dec; 4(4):703-29. PubMed ID: 2126022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Susceptibility to Disseminated Infection with IgA1 Protease-Producing Encapsulated Pathogens Streptococcus pneumoniae, Haemophilus influenzae Type b, and Neisseria meningitidis.
    Kilian M; Husby S; Andersen J; Moldoveanu Z; Sørensen UBS; Reinholdt J; Tettelin H
    mBio; 2022 Jun; 13(3):e0055022. PubMed ID: 35420467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should we plan a general childhood vaccination against bacterial meningitis?
    Mäkelä PH; Peltola H
    Dev Biol Stand; 1979; 43():61-7. PubMed ID: 42596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.
    Zhang Q; Finn A
    J Clin Pathol; 2004 Oct; 57(10):1015-21. PubMed ID: 15452151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter Hospital-Based Prospective Surveillance Study of Bacterial Agents Causing Meningitis and Seroprevalence of Different Serogroups of Neisseria meningitidis, Haemophilus influenzae Type b, and Streptococcus pneumoniae during 2015 to 2018 in Turkey.
    Ceyhan M; Ozsurekci Y; Tanır Basaranoglu S; Gurler N; Sali E; Keser Emiroglu M; Oz FN; Belet N; Duman M; Ulusoy E; Kurugol Z; Tezer H; Ozkaya Parlakay A; Dinleyici EC; Celik U; Celebi S; Oner AF; Solmaz MA; Karbuz A; Hatipoglu N; Devrim I; Caglar I; Bozdemir SE; Kocabas E; Gundeslioglu OO; Sutcu M; Metin Akcan O; Kuyucu N; Aktar F; Kara SS; Altay Akisoglu HO; Tuygun N; Tamburaci Uslu ZD; Karadag Oncel E; Bayhan C; Cengiz AB
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32213620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination.
    Trotter CL; Gay NJ; Edmunds WJ
    Am J Epidemiol; 2005 Jul; 162(1):89-100. PubMed ID: 15961591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of emerging vaccines for childhood meningococcal disease.
    Choudhuri D; Huda T; Theodoratou E; Nair H; Zgaga L; Falconer R; Luksic I; Johnson HL; Zhang JS; El Arifeen S; Nelson CB; Borrow R; Campbell H; Rudan I
    BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S29. PubMed ID: 21501447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Declining Trends of Pneumococcal Meningitis in Gambian Children After the Introduction of Pneumococcal Conjugate Vaccines.
    Sanneh B; Okoi C; Grey-Johnson M; Bah-Camara H; Kunta Fofana B; Baldeh I; Papa Sey A; Labbo Bah M; Cham M; Samateh A; Usuf E; Ndow PS; Senghore M; Worwui A; Mwenda JM; Kwambana-Adams B; Antonio M
    Clin Infect Dis; 2019 Sep; 69(Suppl 2):S126-S132. PubMed ID: 31505634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serogroup A meningococcal conjugate vaccines in Africa.
    Kristiansen PA; Jørgensen HJ; Caugant DA
    Expert Rev Vaccines; 2015; 14(11):1441-58. PubMed ID: 26358167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in bacterial conjugate vaccines.
    Goldblatt D
    J Med Microbiol; 1998 Jul; 47(7):563-7. PubMed ID: 9839559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.